SPRC
SciSparc Ltd.
Price Chart
Latest Quote
$7.41
-0.63 (-7.84%)
Current Price
| Previous Close | $8.04 |
| Open | $7.88 |
| Day High | $7.88 |
| Day Low | $7.36 |
| Volume | 11,771 |
Stock Information
| Shares Outstanding | 573K |
| Total Debt | $366K |
| Cash Equivalents | $4.59M |
| Revenue | $856K |
| Net Income | $-12.18M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market Cap | $4.25M |
| P/E Ratio | 0.08 |
| EPS (TTM) | $98.07 |
| Exchange | NCM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $1.30M |
| Sales | $856K |
| Income | $-12.18M |
| Book/sh | $142.32 |
| Cash/sh | $8.01 |
| Employees | 3 |
Financial Ratios
| Quick Ratio | 2.13 |
| Current Ratio | 2.41 |
| Debt/Eq | 7.11 |
Returns & Margins
| ROA | -60.68% |
| ROE | -178.39% |
| Gross Margin | 73.71% |
| Operating Margin | -848.95% |
Ownership
| Institutional Ownership | 0.57% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| P/S | 4.96 |
| P/B | 0.05 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $8.38 |
| SMA50 | $6.75 |
| SMA200 | $14.96 |
| RSI | 38.97 |
| ATR | 1.6918 |
| Shares Float | 533K |
| Short Float | 65.97% |
| Short Ratio | 0.23 |
| Volatility | 2.43 |
| Rel Volume | 0.01 |
Performance History
| Week | -20.41% |
| Month | +62.86% |
| Quarter | +59.01% |
| 6 Months | -48.86% |
| YTD | -41.19% |
| Year | -87.06% |
| 3 Years | -99.75% |
| 10 Years | -99.97% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-18 | $7.41 | 11,800 |
| 2026-06-17 | $8.04 | 8,500 |
| 2026-06-16 | $8.05 | 22,200 |
| 2026-06-15 | $8.34 | 58,000 |
| 2026-06-12 | $8.55 | 24,300 |
| 2026-06-11 | $9.31 | 33,300 |
| 2026-06-10 | $8.66 | 20,400 |
| 2026-06-09 | $9.31 | 67,300 |
| 2026-06-08 | $10.42 | 41,000 |
| 2026-06-05 | $11.44 | 184,700 |
| 2026-06-04 | $11.54 | 8,819,500 |
| 2026-06-03 | $9.46 | 169,900 |
| 2026-06-02 | $8.73 | 143,400 |
| 2026-06-01 | $10.59 | 387,900 |
| 2026-05-29 | $9.81 | 824,800 |
| 2026-05-28 | $10.55 | 35,706,600 |
| 2026-05-27 | $4.39 | 2,700 |
| 2026-05-26 | $4.47 | 4,100 |
| 2026-05-22 | $4.27 | 19,500 |
| 2026-05-21 | $4.20 | 4,600 |
| 2026-05-20 | $4.10 | 8,500 |
| 2026-05-19 | $4.55 | 2,800 |
About SciSparc Ltd.
SciSparc Ltd., a clinical-stage pharmaceutical company, develops drugs based on cannabinoid therapies. Its drug development programs include SCI-110 for the treatment of Tourette syndrome and Alzheimer's disease and agitation; SCI-210 for the treatment of autism spectrum disorder and status epilepticus; and CannAmide, an anti-inflammatory and chronic pain solution. The company sells hemp seed oil-based products and others. The company has an agreement with Procaps to develop and commercially manufacture SCI-110 and palmitoylethanolamide oral tablets CannAmide in softgel capsule form. It also has an agreement with The Israeli Medical Center for Alzheimer's to conduct a phase IIa clinical trial to evaluate the safety, tolerability, and efficacy of SCI-110 in patients with Alzheimer's disease and agitation; and a collaboration with Clearmind Medicine Inc. The company was formerly known as Therapix Biosciences Ltd. and changed its name to SciSparc Ltd. in January 2021. SciSparc Ltd. was incorporated in 2004 and is headquartered in Tel Aviv-Yafo, Israel.
đ° Latest News
SciSparc announces 1-for-9 reverse share split
TipRanks âĸ 2026-03-03T13:23:28Z
SciSparc And AutoMax Call Off Merger
Benzinga âĸ 2025-10-06T14:55:03Z
Top Midday Gainers
MT Newswires âĸ 2025-09-25T16:36:36ZWall Street Set to Open Little Changed Wednesday as Investors Anticipate Fed Rate Cut
MT Newswires âĸ 2025-09-17T13:19:15Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $185,000 | $684,000 | $631,000 | $322,000 |
| Cost Of Revenue | $225,000 | $800,000 | $683,000 | $322,000 |
| Total Revenue | $856,000 | $1,306,000 | $2,879,000 | $1,347,000 |
| Operating Revenue | $856,000 | $1,306,000 | $2,879,000 | $1,347,000 |
| Expenses | ||||
| Interest Expense | $11,000 | $30,000 | $9,000 | $36,000 |
| Total Expenses | $9,605,000 | $8,548,000 | $8,652,000 | $9,634,000 |
| Other Income Expense | $-5,591,000 | $-635,000 | $-79,000 | $6,949,000 |
| Other Non Operating Income Expenses | $26,000 | - | - | - |
| Net Non Operating Interest Income Expense | $1,776,000 | $391,000 | $-9,000 | $-1,240,000 |
| Total Other Finance Cost | $-1,580,000 | - | $-2,205,000 | $1,204,000 |
| Interest Expense Non Operating | $11,000 | $30,000 | $9,000 | $36,000 |
| Operating Expense | $9,380,000 | $7,748,000 | $7,969,000 | $9,312,000 |
| Other Operating Expenses | $1,562,000 | $128,000 | $110,000 | $80,000 |
| Selling And Marketing Expense | $718,000 | $1,149,000 | $1,998,000 | $1,082,000 |
| General And Administrative Expense | $4,720,000 | $4,290,000 | $3,648,000 | $5,186,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-12,179,000 | $-6,284,000 | $-5,122,000 | $-2,592,000 |
| Net Interest Income | $1,776,000 | $391,000 | $-9,000 | $-1,240,000 |
| Interest Income | $207,000 | $421,000 | $0 | $0 |
| Normalized Income | $-7,062,000 | $-6,078,385 | $-5,222,870 | $-8,026,660 |
| Net Income From Continuing And Discontinued Operation | $-12,179,000 | $-6,284,000 | $-5,122,000 | $-2,592,000 |
| Total Operating Income As Reported | $-8,374,000 | $-7,316,000 | $-6,815,000 | $-8,287,000 |
| Average Dilution Earnings | $0 | $0 | $0 | $0 |
| Net Income Common Stockholders | $-12,179,000 | $-6,284,000 | $-5,122,000 | $-2,592,000 |
| Net Income | $-12,179,000 | $-6,284,000 | $-5,122,000 | $-2,592,000 |
| Net Income Including Noncontrolling Interests | $-12,564,000 | $-7,472,000 | $-5,883,000 | $-2,592,000 |
| Net Income Continuous Operations | $-12,564,000 | $-7,472,000 | $-5,883,000 | $-2,592,000 |
| Pretax Income | $-12,564,000 | $-7,486,000 | $-5,861,000 | $-2,578,000 |
| Special Income Charges | $-3,393,000 | $-74,000 | $-1,042,000 | $0 |
| Earnings From Equity Interest | $-500,000 | $-429,000 | $-210,000 | $-109,000 |
| Interest Income Non Operating | $207,000 | $421,000 | $0 | $0 |
| Operating Income | $-8,749,000 | $-7,242,000 | $-5,773,000 | $-8,287,000 |
| Depreciation Amortization Depletion Income Statement | $194,000 | $366,000 | $486,000 | - |
| Depreciation And Amortization In Income Statement | $194,000 | $366,000 | $486,000 | - |
| Amortization Of Intangibles Income Statement | $194,000 | $366,000 | $486,000 | - |
| Gross Profit | $631,000 | $506,000 | $2,196,000 | $1,025,000 |
| Net Income Discontinuous Operations | - | - | - | - |
| Per Share | ||||
| Diluted EPS | - | $203.89 | $2374.55 | $-1874.19 |
| Basic EPS | - | $203.89 | $2374.55 | $-1874.19 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $-385 | $30,130 | $1,623,340 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-7,202,000 | $-6,768,000 | $-5,445,000 | $-9,413,000 |
| Total Unusual Items | $-5,117,000 | $-206,000 | $131,000 | $7,058,000 |
| Total Unusual Items Excluding Goodwill | $-5,117,000 | $-206,000 | $131,000 | $7,058,000 |
| Reconciled Depreciation | $234,000 | $482,000 | $538,000 | $187,000 |
| EBITDA (Bullshit earnings) | $-12,319,000 | $-6,974,000 | $-5,314,000 | $-2,355,000 |
| EBIT | $-12,553,000 | $-7,456,000 | $-5,852,000 | $-2,542,000 |
| Diluted NI Availto Com Stockholders | $-12,179,000 | $-6,284,000 | $-5,122,000 | $-2,592,000 |
| Minority Interests | $385,000 | $1,188,000 | $761,000 | $0 |
| Tax Provision | $0 | $-14,000 | $22,000 | $14,000 |
| Gain On Sale Of Ppe | $0 | $1,270,000 | $0 | $0 |
| Gain On Sale Of Business | $2,231,000 | $0 | $0 | - |
| Other Special Charges | $5,509,000 | - | - | - |
| Impairment Of Capital Assets | $115,000 | $1,344,000 | $1,042,000 | $0 |
| Gain On Sale Of Security | $-1,724,000 | $-132,000 | $1,173,000 | $7,058,000 |
| Amortization | $194,000 | $366,000 | $486,000 | - |
| Research And Development | $2,186,000 | $1,815,000 | $1,727,000 | $2,964,000 |
| Selling General And Administration | $5,438,000 | $5,439,000 | $5,646,000 | $6,268,000 |
| Other Gand A | $3,159,000 | $3,364,000 | $3,165,000 | $4,116,000 |
| Salaries And Wages | $1,561,000 | $926,000 | $483,000 | $1,070,000 |
| Diluted Average Shares | - | $30,820 | $2,157 | $1,383 |
| Basic Average Shares | - | $30,820 | $2,157 | $1,383 |
| Write Off | - | - | - | $0 |
| Restructuring And Mergern Acquisition | - | - | - | $907,000 |
Fetched: 2026-06-15
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $3,069,000 | $6,675,000 | $4,425,000 | $1,732,000 |
| Total Assets | $7,622,000 | $10,347,000 | $11,182,000 | $10,605,000 |
| Total Non Current Assets | $2,186,000 | $2,844,000 | $4,737,000 | $6,095,000 |
| Investmentin Financial Assets | $997,000 | $354,000 | $659,000 | $730,000 |
| Goodwill And Other Intangible Assets | $1,170,000 | $1,479,000 | $3,189,000 | $4,717,000 |
| Current Assets | $5,436,000 | $7,503,000 | $6,445,000 | $4,510,000 |
| Restricted Cash | $20,000 | $20,000 | $65,000 | $60,000 |
| Prepaid Assets | $88,000 | $350,000 | $275,000 | $40,000 |
| Inventory | $75,000 | $113,000 | $742,000 | $668,000 |
| Receivables | $662,000 | $4,963,000 | $287,000 | $168,000 |
| Other Receivables | $186,000 | $714,000 | $265,000 | $91,000 |
| Loans Receivable | $451,000 | $4,224,000 | $0 | - |
| Accounts Receivable | $10,000 | $10,000 | $22,000 | $77,000 |
| Cash Cash Equivalents And Short Term Investments | $4,591,000 | $2,057,000 | $5,076,000 | $3,574,000 |
| Cash And Cash Equivalents | $4,591,000 | $1,540,000 | $2,076,000 | $3,574,000 |
| Cash Financial | $4,591,000 | $1,540,000 | $2,076,000 | $3,574,000 |
| Debt | ||||
| Total Debt | $366,000 | $46,000 | $76,000 | $27,000 |
| Long Term Debt And Capital Lease Obligation | $0 | $9,000 | $24,000 | $0 |
| Current Debt And Capital Lease Obligation | $366,000 | $37,000 | $52,000 | $27,000 |
| Current Debt | $356,000 | - | - | - |
| Other Current Borrowings | $356,000 | - | - | - |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $2,475,000 | $1,408,000 | $1,595,000 | $4,156,000 |
| Total Non Current Liabilities Net Minority Interest | $222,000 | $9,000 | $24,000 | $0 |
| Tradeand Other Payables Non Current | $0 | $0 | - | - |
| Current Liabilities | $2,253,000 | $1,399,000 | $1,571,000 | $4,156,000 |
| Other Current Liabilities | $340,000 | $341,000 | $532,000 | $2,737,000 |
| Payables And Accrued Expenses | $1,372,000 | $891,000 | $883,000 | $1,315,000 |
| Payables | $1,287,000 | $816,000 | $835,000 | $312,000 |
| Accounts Payable | $783,000 | $816,000 | $802,000 | $298,000 |
| Other Payable | - | - | $33,000 | $14,000 |
| Equity | ||||
| Common Stock Equity | $4,239,000 | $8,154,000 | $7,614,000 | $6,449,000 |
| Total Equity Gross Minority Interest | $5,147,000 | $8,939,000 | $9,587,000 | $6,449,000 |
| Stockholders Equity | $4,239,000 | $8,154,000 | $7,614,000 | $6,449,000 |
| Other Equity Interest | $13,005,000 | $11,746,000 | $11,282,000 | $10,929,000 |
| Gains Losses Not Affecting Retained Earnings | $1,907,000 | $497,000 | $497,000 | $497,000 |
| Retained Earnings | $-87,154,000 | $-74,975,000 | $-68,691,000 | $-63,569,000 |
| Long Term Equity Investment | $0 | $952,000 | $781,000 | $591,000 |
| Other | ||||
| Ordinary Shares Number | $365,443 | $57,292 | $3,739 | $1,383 |
| Share Issued | $365,443 | $57,292 | $3,739 | $1,383 |
| Tangible Book Value | $3,069,000 | $6,675,000 | $4,425,000 | $1,732,000 |
| Invested Capital | $4,595,000 | $8,154,000 | $7,614,000 | $6,449,000 |
| Working Capital | $3,183,000 | $6,104,000 | $4,874,000 | $354,000 |
| Capital Lease Obligations | $10,000 | $46,000 | $76,000 | $27,000 |
| Total Capitalization | $4,239,000 | $8,154,000 | $7,614,000 | $6,449,000 |
| Minority Interest | $908,000 | $785,000 | $1,973,000 | $0 |
| Foreign Currency Translation Adjustments | $1,907,000 | $497,000 | $497,000 | $497,000 |
| Capital Stock | $76,481,000 | $70,886,000 | $64,526,000 | $58,592,000 |
| Common Stock | $76,481,000 | $70,886,000 | $64,526,000 | $58,592,000 |
| Dueto Related Parties Non Current | $222,000 | $0 | - | - |
| Long Term Capital Lease Obligation | $0 | $9,000 | $24,000 | $0 |
| Current Capital Lease Obligation | $10,000 | $37,000 | $52,000 | $27,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $175,000 | $130,000 | $104,000 | $77,000 |
| Current Accrued Expenses | $85,000 | $75,000 | $48,000 | $1,003,000 |
| Dueto Related Parties Current | $504,000 | $0 | - | - |
| Investments And Advances | $997,000 | $1,306,000 | $1,440,000 | $1,321,000 |
| Investmentsin Associatesat Cost | $0 | $952,000 | $781,000 | $591,000 |
| Net PPE | $19,000 | $59,000 | $108,000 | $57,000 |
| Accumulated Depreciation | $-81,000 | $-40,000 | $-117,000 | $-65,000 |
| Gross PPE | $100,000 | $99,000 | $225,000 | $122,000 |
| Machinery Furniture Equipment | $25,000 | $24,000 | $44,000 | $44,000 |
| Buildings And Improvements | $75,000 | $75,000 | $181,000 | $78,000 |
| Properties | $0 | $0 | $0 | $0 |
| Finished Goods | $75,000 | $113,000 | $742,000 | $668,000 |
| Duefrom Related Parties Current | $15,000 | $15,000 | $0 | - |
| Other Short Term Investments | $0 | $517,000 | $3,000,000 | $0 |
| Leases | - | - | $181,000 | $78,000 |
Fetched: 2026-06-15
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-4,137,000 | $-5,104,000 | $-5,887,000 | $-12,786,000 |
| Operating Activities | ||||
| Operating Cash Flow | $-4,137,000 | $-5,104,000 | $-5,887,000 | $-7,917,000 |
| Cash Flow From Continuing Operating Activities | $-4,137,000 | $-5,104,000 | $-5,887,000 | $-7,917,000 |
| Operating Gains Losses | $1,470,000 | $734,000 | $1,258,000 | $879,000 |
| Investing Activities | ||||
| Investing Cash Flow | $-1,400,000 | $-1,625,000 | $-4,094,000 | $-7,084,000 |
| Cash Flow From Continuing Investing Activities | $-1,400,000 | $-1,625,000 | $-4,094,000 | $-7,084,000 |
| Net Other Investing Changes | $-2,000,000 | $-4,033,000 | $-5,000 | $-15,000 |
| Capital Expenditure | - | - | - | $-4,869,000 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $2,972,000 | $6,255,000 | $5,552,000 | $9,005,000 |
| Financing Cash Flow | $8,588,000 | $6,193,000 | $8,483,000 | $11,700,000 |
| Cash Flow From Continuing Financing Activities | $8,588,000 | $6,193,000 | $8,483,000 | $11,700,000 |
| Cash Dividends Paid | $0 | $0 | $0 | $0 |
| Net Common Stock Issuance | $2,972,000 | $6,255,000 | $5,552,000 | $9,005,000 |
| Common Stock Issuance | $2,972,000 | $6,255,000 | $5,552,000 | $9,005,000 |
| Net Other Financing Charges | - | - | $2,985,000 | $3,000 |
| Other | ||||
| Repayment Of Debt | $-38,000 | $-54,000 | $-47,000 | $-70,000 |
| Issuance Of Debt | $4,538,000 | $0 | $0 | $0 |
| End Cash Position | $4,591,000 | $1,540,000 | $2,076,000 | $3,574,000 |
| Beginning Cash Position | $1,540,000 | $2,076,000 | $3,574,000 | $6,875,000 |
| Changes In Cash | $3,051,000 | $-536,000 | $-1,498,000 | $-3,301,000 |
| Interest Paid Cff | $-5,000 | $-8,000 | $-7,000 | $-8,000 |
| Proceeds From Stock Option Exercised | $1,121,000 | $0 | $0 | $2,770,000 |
| Net Issuance Payments Of Debt | $4,500,000 | $-54,000 | $-47,000 | $-70,000 |
| Net Short Term Debt Issuance | $192,000 | $0 | $0 | $0 |
| Short Term Debt Issuance | $192,000 | $0 | $0 | $0 |
| Net Long Term Debt Issuance | $4,308,000 | $-54,000 | $-47,000 | $-70,000 |
| Long Term Debt Payments | $-38,000 | $-54,000 | $-47,000 | $-70,000 |
| Long Term Debt Issuance | $4,346,000 | $0 | $0 | - |
| Net Investment Purchase And Sale | $0 | $3,000,000 | $-3,689,000 | $-1,500,000 |
| Sale Of Investment | $0 | $3,000,000 | - | - |
| Purchase Of Investment | $0 | $0 | $-3,689,000 | $-1,500,000 |
| Net Business Purchase And Sale | $600,000 | $-600,000 | $-400,000 | $-700,000 |
| Sale Of Business | $700,000 | $0 | $0 | $0 |
| Purchase Of Business | $-100,000 | $-600,000 | $-400,000 | $-700,000 |
| Net PPE Purchase And Sale | $0 | $8,000 | $0 | $-8,000 |
| Change In Working Capital | $1,445,000 | $136,000 | $-833,000 | $-703,000 |
| Change In Other Working Capital | $726,000 | $-15,000 | - | - |
| Change In Payables And Accrued Expense | $-109,000 | $45,000 | $-405,000 | $39,000 |
| Change In Payable | $-109,000 | $45,000 | $-405,000 | $39,000 |
| Change In Account Payable | $-164,000 | $25,000 | $-397,000 | $0 |
| Change In Inventory | $38,000 | $629,000 | $-74,000 | $-668,000 |
| Change In Receivables | $790,000 | $-523,000 | $-354,000 | $-74,000 |
| Changes In Account Receivables | $0 | $12,000 | $55,000 | $-77,000 |
| Other Non Cash Items | $-1,998,000 | $-897,000 | $-2,205,000 | $-6,585,000 |
| Stock Based Compensation | $1,188,000 | $569,000 | $196,000 | $897,000 |
| Asset Impairment Charge | $6,088,000 | $1,344,000 | $1,042,000 | $0 |
| Depreciation Amortization Depletion | $234,000 | $482,000 | $538,000 | $187,000 |
| Depreciation And Amortization | $234,000 | $482,000 | $538,000 | $187,000 |
| Earnings Losses From Equity Investments | $-1,731,000 | $429,000 | $210,000 | $109,000 |
| Gain Loss On Investment Securities | $1,791,000 | $305,000 | $1,048,000 | $770,000 |
| Net Foreign Currency Exchange Gain Loss | $1,410,000 | $0 | $0 | - |
| Net Income From Continuing Operations | $-12,564,000 | $-7,472,000 | $-5,883,000 | $-2,592,000 |
| Net Intangibles Purchase And Sale | - | $0 | $0 | $-4,861,000 |
| Purchase Of Intangibles | - | $0 | $0 | $-4,861,000 |
| Short Term Debt Payments | - | - | $0 | $0 |
| Purchase Of PPE | - | - | $0 | $-8,000 |
| Effect Of Exchange Rate Changes | - | - | - | - |
| Sale Of PPE | - | - | - | - |
| Gain Loss On Sale Of PPE | - | - | - | - |
Fetched: 2026-06-15